| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $42.97M | $27.55M | $23.41M | $32.56M | $38.63M |
| R&D | $33.72M | $19.39M | $16.53M | $24.47M | $29.11M |
| SG&A | $9.25M | $8.16M | $6.88M | $8.10M | $9.52M |
| Operating Income | -$42.97M | -$27.55M | -$23.41M | -$32.56M | -$38.63M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$15.28M | -$62.29M | -$27.03M | -$41.31M | -$43.24M |
| EPS (basic) | -0.1900 | -1.0200 | -0.5600 | -0.8900 | -1.0300 |
| EPS (diluted) | -0.5300 | -1.0200 | -0.5600 | -0.8900 | -1.0300 |
| Shares (diluted) | $79.74M | $60.99M | $48.03M | $46.55M | $41.85M |